0.3089
前日終値:
$0.3256
開ける:
$0.337
24時間の取引高:
587.43K
Relative Volume:
0.17
時価総額:
$53.17M
収益:
-
当期純損益:
$-41.23M
株価収益率:
-0.4413
EPS:
-0.7
ネットキャッシュフロー:
$-11.54M
1週間 パフォーマンス:
-2.52%
1か月 パフォーマンス:
-13.64%
6か月 パフォーマンス:
-65.32%
1年 パフォーマンス:
-75.29%
Renovaro Inc Stock (RENB) Company Profile
名前
Renovaro Inc
セクター
電話
45 39179840
住所
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
RENB を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RENB
Renovaro Inc
|
0.3089 | 73.49M | 0 | -41.23M | -11.54M | -0.70 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Renovaro Inc (RENB) 最新ニュース
Renovaro chairman Maurice van Tilburg to step down in August - Investing.com
Is Renovaro Inc. a good long term investmentHigh-impact investment strategies - PrintWeekIndia
Renovaro Biosciences Chairman Announces Resignation - TipRanks
Renovaro Inc. Stock Analysis and ForecastHigh-profit capital plays - PrintWeekIndia
What drives Renovaro Inc. stock priceJaw-dropping returns - Autocar Professional
What analysts say about Renovaro Inc. stockTremendous portfolio expansion - Autocar Professional
How high can Renovaro Inc. stock price go in 2025Tremendous return rates - jammulinksnews.com
Can Renovaro Inc. stock recover from recent declineDaily Breakout Picks - Newser
What makes Renovaro Inc. stock price move sharplySmart Return Focused Trading - Newser
Renovaro Biosciences (RENB) Achieves Milestone with Innovative C - GuruFocus
Revolutionary Dendritic Cell Therapy Slashes Pancreatic Cancer Tumors by 81% in Groundbreaking Study - Stock Titan
Renovaro Inc (RENB) Stock: A Comprehensive 52-Week Review - investchronicle.com
Renovaro BioSciences announces publication of study on dendritic cell therapy - TipRanks
How did Renovaro's expenses impact profits in Q2 2025? - AInvest
Renovaro Rockets 20% Higher on Legal Drama—Biotech's High-Stakes Merger Showdown - AInvest
Why Renovaro Inc. stock attracts strong analyst attentionFree Stock Market Expert Consultation - Newser
How Renovaro Inc. stock performs during market volatilityFree Consultation - Newser
Renovaro receives Nasdaq notice for missing annual shareholder meeting - Investing.com Australia
Renovaro receives Nasdaq notice for missing annual shareholder meeting By Investing.com - Investing.com Nigeria
Renovaro Inc (RENB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):